News
Reported cumulative MMR rate of 47% (25 of 53) by 24 weeks with 32% (13 of 41) of patients achieving MMR by 24 weeks, which continues to compare favorably to precedent ...
Reported cumulative MMR rate of 47% (25 of 53) by 24 weeks with 32% (13 of 41) of patients achieving MMR by 24 weeks, which ...
Viruses closely related to the deadly MERS coronavirus are lurking in bats and one group, known as HKU5, may be just one mutation away from making the jump to humans. A new study reveals how these ...
A new COVID-19 variant called NB.1.8.1, aka "Nimbus," is spreading rapidly in the United States, CDC data show. What to know ...
In a critical step toward addressing food insecurity in West Africa, the International Atomic Energy Agency (IAEA) and the Food and Agriculture Organization (FAO) of the United Nations have launched ...
Robust responses observed across subgroups, regardless of co-mutations, number of prior lines of therapy, or prior venetoclax, within efficacy-evaluable pivotal R/R mNPM1 AML population – – 60% (3/5) ...
Golidocitinib demonstrated promising efficacy in maintaining and enhancing tumor response in peripheral T-cell lymphoma (PTCL ...
Click in for more news from The Hill{beacon} Health Care Health Care The Big Story Vaccine critics among new ACIP ...
The World Health Organization (WHO) is keeping an eye on a new COVID-19 variant called NB.1.8.1, or "Nimbus," that has spread ...
The Food Standards Agency (FSA) said they contain mineral oil hydrocarbons, which come from raw crude oil and other fossil ...
Health officials are tracking a highly contagious new COVID-19 variant. This comes as confusion grows over vaccine ...
In mice, engineered immune cells shrink pancreatic and other tumours bearing a mutant version of the KRAS protein.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results